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Abstract
Objective To systematically review and describe currently available
approaches to supporting maintenance of weight loss in obese adults
and to assess the evidence for the effectiveness of these interventions.
Design Systematic review with meta-analysis.
Data sourcesMedline, PsycINFO, Embase, and the Cochrane Central
Register of Controlled Trials.
Study selection Studies were identified through to January 2014.
Randomised trials of interventions to maintain weight loss provided to
initially obese adults (aged ≥18) after weight loss of ≥5% body weight
with long term (≥12 months) follow-up of weight change (main outcome)
were included.
Study appraisal and synthesis Potential studies were screened
independently and in duplicate; study characteristics and outcomes were
extracted. Meta-analyses were conducted to estimate the effects of
interventions on weight loss maintenance with the inverse variance
method and a random effects model. Results are presented as mean
differences in weight change, with 95% confidence intervals.
Results 45 trials involving 7788 individuals were included. Behavioural
interventions focusing on both food intake and physical activity resulted
in an average difference of −1.56 kg (95% confidence interval −2.27 to
−0.86 kg; 25 comparisons, 2949 participants) in weight regain compared
with controls at 12 months. Orlistat combined with behavioural
interventions resulted in a −1.80 kg (−2.54 to −1.06; eight comparisons,
1738 participants) difference compared with placebo at 12 months. All
orlistat studies reported higher frequencies of adverse gastrointestinal
events in the experimental compared with placebo control groups. A
dose-response relation for orlistat treatment was found, with 120 mg
doses three times a day leading to greater weight loss maintenance
(−2.34 kg, −3.03 to −1.65) compared with 60 mg and 30 mg three times
a day (−0.70 kg, 95% confidence interval −1.92 to 0.52), P=0.02.
Conclusions Behavioural interventions that deal with both diet and
physical activity show small but significant benefits on weight loss
maintenance.
Introduction
Obesity is one of the greatest causes of preventable morbidity
and mortality worldwide,1 with weight loss associated with
reductions in risk of morbidity and mortality.2 Evidence from
systematic reviews suggests that long term weight loss through
changes in eating and physical activity is possible,3 even in
adults who have already acquired obesity related illness,4 and
effective weight loss programmes are now available.5 Wardle
and colleagues reported that 28% of adults in the United
Kingdom claimed to be actively trying to lose weight.6 In a
population survey based in the United States, Nicklas and
colleagues found that that 63% of obese participants had
attempted to lose weight over the past 12 months, of whom 40%
had succeeded in losing ≥5% of their initial weight and 20%
had succeeded in losing ≥10%.7 Though formal behaviour
change interventions and self guided efforts at individual
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behaviour change are successful in inducing weight loss,
however, few people manage to maintain these changes in
weight over the long term.8 Weight loss from behavioural
interventions typically peaks at around six months into the
weight loss attempt, followed by gradual regain of weight in
most individuals.3 4Asmaintenance of the weight loss is crucial
to uphold health benefits,9 understanding how best to support
people in sustaining weight loss is paramount to controlling the
obesity epidemic and its consequences.
Compared with initiation of weight loss, the evidence base for
maintenance of weight loss is in its infancy. A recent systematic
review of 13 randomised controlled trials examining effects of
“extended care” for weight loss maintenance reported an average
3.2 kg difference in weight regain between extended care and
no or minimal additional contact.10 Other reviews that have
examined weight loss maintenance studies confirm the potential
of successful maintenance treatment, although there is
considerable heterogeneity between studies. Currently available
reviews are limited by not usingmeta-analyses,11-14 no separation
of studies focused on weight loss or maintenance,11 12 the use
of restrictive inclusion criteria focusing on specific subsets of
non-surgical studies,10-12 inclusion of non-randomised trials,12 13
or a lack of systematic identification of studies.13 To date, no
comprehensive systematic review of long term effects of
non-surgical treatments for maintenance of weight loss tested
in randomised controlled trials is available to examine the effects
of different treatments in the prevention of weight regain. We
describe currently available non-surgical interventions for weight
loss maintenance and have synthesised the randomised
controlled evidence for the effectiveness of interventions and
intervention delivery features.
Methods
The systematic review was conducted in line with Cochrane
recommendations15 following a pre-specified protocol.
Eligibility criteria
Types of studies—We included randomised controlled trials or
cluster randomised controlled trials with participants randomised
to a weight maintenance intervention compared with a control
condition or another intervention, or both, and ≥12 months’
follow-up of weight outcomes from inception of themaintenance
intervention.
Types of participants—Participants were adults (aged ≥18, no
upper age limit) who had, or had had, an average BMI of ≥30
and lost ≥5% of their bodyweight/mass within 24months before
weight loss maintenance treatment. We excluded studies that
recruited participants with established mental health conditions,
including eating disorders, and conditions requiring treatment
with antipsychotic drugs.
Type of interventions—Any behavioural/lifestyle,
pharmacological (with European Medicines Agency approval
for weight loss), food replacement/supplement, or alternative
interventions, singly or in combination were included. We
excluded surgical interventions.
Types of outcomes—Primary outcomewas weight at 12months
from randomisation to the weight loss maintenance intervention.
Weight could be reported as absolute weight change during the
trial including the weight loss phase, weight change during the
maintenance treatment period, or final weight values.
Types of reports—Full text reports in any language from 1946
to January 2014.
Electronic searches
We searched the electronic databases Medline, PsycINFO,
Embase, and Cochrane Central Register of Controlled Trials
(CENTRAL) using a comprehensive search strategy. We also
conducted hand searches of all references of included studies
and those of previous relevant reviews.10 13 14
Study selection
Three authors (SUD, FFS, and VA-S) double scanned all
references identified through the search strategy for initial
selection. Full texts of potentially eligible studies were obtained,
and two authors (SUD, FFS) verified inclusion using a
prespecified eligibility form.
Data extraction
We extracted risk of bias items, modes of intervention delivery,
study design, study flow, participant details, outcomemeasures,
and funding source. Risk of bias was assessed based on the
Cochrane Collaboration’s tool.15 Intervention delivery was
assessed based on the criteria of Davidson and colleagues,16
including intervention provider, format and delivery, setting,
duration and intensity, and materials. Two researchers per study
(from SUD, KK, VAS) coded intervention delivery based on
published articles as well as publicly and freely available
protocols and full manuals. Disagreements were resolved by a
third researcher (FFS). One researcher (SUD) extracted study
information and modes of intervention delivery, which were
checked by another (KK). Two researchers (SUD, KK)
independently assessed risk of bias. Disagreements were
resolved by a third researcher (FFS).
Data analysis
All inter-rater agreements for risk of bias items were assessed
with Krippendorf’s α (which ranges from 1 (perfect agreement)
to 0 (no agreement) and has been found to be superior to other
reliability coefficients17). Studies reporting sufficient data to
calculate mean differences in weight change in kg with 95%
confidence intervals were considered formeta-analysis (RevMan
version 5.1). Meta-analyses combined weight changes overall
(that is, including an initial weight loss phase) or weight change
of the maintenance phase only.When a choice of weight related
outcomemeasures was available (such as completer only versus
baseline observation carried forward) we chose the most
conservative effect estimate provided. When studies reported
average weight at baseline and follow-up we calculated weight
change by subtracting the final from the initial weight at the
start of maintenance. Standard deviations for weight change
were imputed according to the formula provided Avenell and
colleagues.3 Data that were reported only in graphical form18-20
were digitised with Engauge Digitizer, version 4.1 (http://
sourceforge.net), to extract data in the most precise and
replicable manner possible. All pooled effects were calculated
as mean difference in weight change by using random effects
model (inverse-variance approach). Mean differences were
calculated for 12, 18, 24, 30, and 36 after the start of the
maintenance intervention (outcomes at ≥3 months were
integrated into the closest respective time points).15Consistency
across study effects was assessed with I2.21 I2 >25% and >50%
were interpreted as an indicator for moderate and substantial
heterogeneity, respectively. Publication bias was assessed by
plotting the inverse of the standard errors of effect estimates
with funnel plots to explore symmetry, which were assessed
visually, as well as with use of Egger’s regression test using the
“metabias” macros in STATA 13. The test for subgroup
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differences available in RevMan 5.1 was used to determine
whether there was evidence for a difference in treatment effect
between groups.
Types of comparisons
Comparisons were made for the following intervention types:
behavioural/lifestyle based on both dietary and physical activity
approaches; dietary, physical activity; pharmacological; food
supplement; andmeal replacement. Control conditions included
no intervention, standard or minimal care or placebo controlled
conditions, or conditions that controlled for a relevant
intervention component to allow comparison. In addition, we
examined three delivery modes (intensive v less intensive;
internet v control; person v remote delivery—that is, internet or
phone).
When studies tested multiple interventions against a comparison
condition, we split the comparison group sample size by the
number of intervention groups to capture heterogeneity across
maintenance intervention arms. Studies that used a factorial
design were treated as separate studies for the relevant factors.
Findings for comparisons that could not be included in any
meta-analyses are summarised narratively.
Sensitivity analyses
To examine the robustness of findings we conducted several
sensitivity analyses:
Strength related sensitivity analyses—when studies
contributed multiple study arms for a meta-analysis we
examined the most intensive intervention arm. When
judgment of intervention intensity was not possible, we
combined both intervention arms with the methods outlined
above
Dose-response related sensitivity analyses—when studies
provided the intervention components in different doses
these were analysed in separate subgroups
Focus related sensitivity analyses—when studies were
combined for a particular general feature (such as physical
activity), we examined the impact of specific focus areas
(such as walking) separately when possible
Risk of bias analyses—we examined whether allocation
concealment (adequate v unclear/no) and outcome assessment
(adequate v unclear/no) influenced outcomes for the main
findings.
Results
Study selection
The search identified 3735 potentially relevant records, of which
127 were selected as potentially eligible; 42 papers describing
45 studies met inclusion criteria (fig 1⇓). The table summarises
overall details of the studies, with full details provided in
appendix 1.⇓
Risk of bias
The average inter-rater agreement for risk of bias indicators was
good (Krippendorf’s α =0.82). Allocation concealment was
judged to be adequate in 10 studies and unclear in 35 (fig 2)⇓.
Seventeen studies reported blinding, including descriptions of
blinding of participants (n=14), interveners (n=13), data analysts
(n=4), and outcome assessors (n=9). Blinding of participants,
interveners, data analysts, and outcome assessors was judged
to be adequate for three, none, one, and four studies,
respectively. Data analysis of all participants (for example, last
entry carried forward or baseline observation carried forward)
was reported by 23 studies, and incomplete outcome data was
judged to be adequately dealt with in 25 studies.
Study characteristics—intervention
descriptions
Studies were published in 1984-2013.Most studies (n=28) were
conducted in the US; other locations were Europe (15), New
Zealand (n=1), and Australia (n=1). The weighted average age
of participants was 47.3 and the weighted average BMI before
weight loss was 35.2. Trials included a mix of overweight and
obese women and men (n=29) or only women (n=13) or men
(n=3). Studies sampling both women and men included a
weighted average of 73.3% women.
Three studies recruited individuals who had lost weight in the
community,22-24 with the 42 remaining providing weight loss
treatment before weight loss maintenance. The 42 studies
including a weight loss induction phase initially recruited 9451
individuals, of whom 7788 were included in the maintenance
phase (average dropout of 28.4% before maintenance). Initial
attrition was mainly because of study dropout, although failure
to meet weight loss and/or adherence criteria prevented entry
into the maintenance phase for individuals in 17 studies. A total
of 6278 individuals completed weight maintenance treatment
(additional average dropout of 20%). Fourteen studies disclosed
funding from industry.18 19 25-35
Initial weight loss phases
Of the 42 studies that included a formal weight loss phase, the
average weight loss across studies ranged from −4.03 kg36 to
−21.3 kg,29 with a weighted average of averages of −10.8 kg.
The length of weight loss treatment before the maintenance
phase ranged from two to 12 months (median 4.0). Most
advocated change in behaviour/lifestyle, diet, and physical
activity (n=26), commonly referred to as “standard behavioural
therapy.” Other studies used a diet only (n=11) or physical
activity only (n=1) approach. Some studies used a combination
of pharmacotherapy in addition to behavioural/lifestyle change
(n=3) or placebo treatment for pharmacotherapy and
behavioural/lifestyle change (n=1). The dietary approaches
advocated were described as general energy deficit diets (n=14),
very low energy diets (defined as ≤800 kcal (3344 kJ)/day,
n=11), low energy diets (defined as ≤1500 kcal (6270 kJ)/day,
n=7), and a combination of the two (n=4). Some studies provided
no detail (n=6) or explicitly stated not using a dietary approach
for weight loss (n=1).
The physical activity recommendations for weight loss varied
considerably, withwalking as themost commonly recommended
activity (n=4). Intensity of recommended physical activity varied
from 20-30 minutes three to five times a week27 to 60 minutes
every day.23 Two studies provided exercise classes.26 37 Most
studies provided no details of recommendations for physical
activity.
Several studies (n=17) reported a formal weight loss criterion
for entry into the weight loss maintenance treatment. Entry
criteria ranged from 5% to 10% of original body weight or 4-8
kg of initial weight loss. Three studies recruiting from the
community without a formal weight loss phase required
objective evidence of either 5% weight loss in the previous six
months22 or 10%weight loss in the previous one24 or two years.23
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Weight loss maintenance phase
For maintenance of weight loss, most studies examined
behavioural/lifestyle interventions for diet and physical activity
(n=22). Some studies focused on dietary (n=3) or exercise
approaches (n=2) only. Other interventions included
pharmacological (n=5), meal replacement (n=5), food
supplement (n=3), or other (n=2) interventions.
Most study arms for which dietary approaches were reported
continuing to prescribe energy deficit diets (n=23), while others
prescribed diets to maintain body weight (n=14). Some arms
were not prescribed any diet (n=7), and others were prescribed
a mixture of weight loss and weight loss maintenance diets,
depending onweightmaintenance goals (n=3).Most descriptions
of interventions, however, were unclear or provided no detail
as to whether dietary approaches targeted further weight loss
or maintenance of existing weight loss.
Recommendations for physical activity mostly promoted a
general increase in physical activity (n=22). Some interventions
provided specific recommendations, including walking (n=8)
or resistance training (n=1) or provided exercise classes (n=2).
Nine studies advocated maintenance of the physical activity
levels recommended in the previous weight loss phase. Many
studies did not provide details of physical activity to maintain
weight loss, were unclear, or did not provide physical activity
recommendations.
The five studies prescribing pharmacotherapy used orlistat at
different doses (30, 60, or 120 mg three times daily). The three
studies examining dietary supplements included conjugated
linoleic acid (n=1), fibre (n=1), carbohydrate, or a combination
of carbohydrate, fibre, chromium picolinate, and caffeine (n=1).
The five studies examiningmeal replacements included Optifast
(n=2), Nutrilet (n=1), the Cambridge diet (n=1), or the option
of food boxes containing food in line with the recommended
diet (n=1). The two studies examining alternative treatments
included the use of a corset (n=1) and acupressure (n=1).
Modes of delivery
Intervention provider—Intervention arms delivered in person
were facilitated by one (n=59) or multiple (n=23) types of
providers, including “therapists” (n=21), dietitians (n=21),
general practitioners/physicians (n=14), nurses (n=11),
nutritionists (n=11), physiotherapist/exercise instructors (n=6),
peer support (n=3), students (n=3), peers (n=3), or acupressure
practitioner (n=1).
Format and delivery—Most studies were delivered either in a
group (n=42) or combined group and individual (n=17) format.
Other delivery formats included individual (n=5), internet (n=5),
mail (n=5), telephone (n=3), mail and telephone (n=2), or group,
mail, and telephone (n=1).
Setting—Research settings were generally poorly described.
Those that reported study settings included home, often through
the internet or phone (n=19), clinics (n=15), community (n=3),
interactive television studio (n=2), or gym based settings (n=1).
Duration and intensity—Most weight loss maintenance
interventions lasted 12 months (n=42) and ranged from 3-36
months (median 12.0). Intensity of intervention arms ranged
from a minimum of once every three months27 to a maximum
of 17 intervention contacts a month,26 with a mean of 3.2 (SD
3.19) contacts a month. Longer interventions tended to offer
more intervention contacts, r=0.45, P<0.001.
Materials—Most provided materials were paper based such as
session handouts or self monitoring cards/booklets (n=35). Other
materials included the provision of pharmacological agents and
corresponding placebos, food supplements, ormeal replacements
(n=20). Some studies offered incentives and refunded money,
provided lottery tickets, or coupons (n=6); one study provided
participants with corsets (n=1).34 One trial provided two study
arms with scales for regular self weighing and a toolbox of
materials that were accessed depending on progress (n=2).23
Meta-analysis—intervention effectiveness
Table A in appendix 2 provides a summary of all meta-analytic
findings.
Behavioural/lifestyle v control
At 12 months, 15 behavioural/lifestyle studies including 25
comparisons20 23 24 36 38-48 showed a mean difference in weight
change of −1.56 kg (95% confidence interval −2.27 to −0.86
kg; I2=36%; fig 3⇓).
Though Egger’s test was non-significant (P=0.14), inspection
of the funnel plots does suggest small study bias (see fig A in
appendix 2). Removal of four outlier comparisons with small
numbers of participants and large effects that all came from a
single study45 decreased the mean difference to −1.37 kg (95%
confidence interval −2.02 to −0.73 kg; I2=27%). Sensitivity
analysis including only the most intensive intervention arms
from multi-arm trials found a mean difference of −1.69 kg
(−2.47 to −0.92 kg; I2=40%) compared with controls. Sensitivity
analysis by risk of bias items showed no differences between
subgroups in relation to adequate allocation concealment or
outcome assessment.
At 18 months, seven studies including 13 comparisons could
be meta-analysed.20 23 24 42 44 45 49 The overall mean difference in
weight change was −1.96 kg (95% confidence interval −2.73
to −1.20 kg; I2=15%). Sensitivity analysis including only the
most intensive intervention arms from multi-arm studies found
a mean difference in weight change of −2.22 kg (−3.18 to −1.26
kg; I2=26%). Sensitivity analysis for risk of bias items showed
no significant differences in mean differences between
subgroups in relation to adequate allocation concealment
(adequate −1.49 kg (−2.24 to −0.73 kg) v unclear −2.92 kg
(−4.31 to −1.54 kg), test for subgroup differences P=0.07;
I2=69%) and outcome assessment (adequate −1.64 kg (−2.31
to −0.96 kg) v unclear −3.74 kg (−5.80 to −1.67 kg), test for
subgroup differences P=0.06; I2=72%). At 24 and 30 months
two studies reported outcomes.18 23 Overall mean differences in
weight change remained significant at 24 months (−1.48 kg,
−2.27 to −0.69 kg; I2=0%) but not at 30 months (−0.85 kg,
−1.81 to 0.11 kg; I2=0%). No adverse events were reported for
any behavioural/lifestyle weight loss maintenance treatments.20 24
Pharmacological interventions
At 12 months, four pharmacological intervention studies
including eight comparisons examined the effects of orlistat
combined with lifestyle change compared with placebo and
lifestyle change.18 19 27 50 The overall mean difference was −1.80
kg (95% confidence interval −2.54 to −1.06 kg; I2=34%) (fig
4⇓). Subgroup analyses by dose of orlistat (120 mg v 60/30 mg
three times daily) showed a dose-response relation, with studies
that used 120 mg of orlistat displaying a mean difference of
−2.34 kg (−3.03 to −1.65 kg, I2=0%) compared with −0.70 kg
(−1.92 to 0.52 kg; I2=13%) in studies that used a 60/30 mg dose.
The treatment effect was significantly greater in the subgroup
of studies that used a 120 mg dose of orlistat (test for subgroup
differences P=0.02; I2=81%).
One study testing the 120mg dose provided long term follow-up
at 18 and 36 months, with mean differences of −2.10 kg (95%
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confidence interval −4.09 to −0.11 kg) and −2.20 kg (−4.01 to
−0.39 kg), respectively.18
All pharmacological studies reported increased adverse events
in those taking orlistat compared with placebo groups (see table
B in appendix 2). There was an increased frequency of
gastrointestinal events in participants taking orlistat, with some
studies reporting increased numbers withdrawing for this
reason16 50. Gastrointestinal events were described as mild to
moderate in intensity16 50 and occurring in the early phase of the
intervention.16 19 50 No differences in other types of adverse
events were reported. Two studies report minimal systemic
absorption of orlistat.16 43 Two studies reported small significant
decreases in vitamin status in participants taking orlistat, which
remained within the normal clinical ranges and were treatable
through vitamin supplementation.16 19
Other interventions
There was no evidence of effectiveness for the following
interventions: dietary interventions versus control condition,35 37
high carbohydrate and low fat diets versus other types of
diets,22 33 51 physical activity interventions versus control
conditions,35 37 42 adding aerobic exercise to a dietary intervention
versus diet alone,42 45 adding physical activity (such as walking
and resistance training) to a dietary intervention versus diet
alone,26 28 or adding meal replacements to dietary
recommendations versus dietary recommendations alone.25 48 52-54
Details are in table A, appendix 2.
Other studies found no evidence for the effectiveness of
nutritional supplements in addition to a dietary regimen versus
the diet itself and placebo supplements55 or no supplements,30 31
Tapas acupressure technique versus social support,56 mailing
computer generated individualised reports based on the
“transtheoretical” model versus generic action oriented
information,57 gourmet cooking versus neurolinguistic
programming based therapy,32 a motivation focused versus a
skill focused intervention,58 or providing participants with a
corset over nine months versus no corset.34 One study reported
that wearing a corset was perceived as uncomfortable34—no
other comments about weight loss maintenance treatments were
reported.
Mode of delivery of intervention
There was no evidence of effectiveness for more intensive
interventions in terms of frequency of contact22 or number of
intervention components59 versus less intensive versions of the
intervention,22 59 internet delivered lifestyle/behavioural
interventions versus control groups,20 23 38-40 43 or the delivery of
a lifestyle/behavioural intervention through face to face contact
versus remote delivery (such as phone/internet) of the same
intervention.20 23 39 40 43
Discussion
Principal findings
This comprehensive systematic review of interventions for
maintenance of non-surgical weight loss suggests that it is
possible to reduce weight regain through behavioural and
pharmacological means. Lifestyle interventions targeting both
dietary intake and physical activity are effective in reducing
weight regain after initial weight loss in obese adults within 12
months of weight loss. There is some evidence that these effects
can be further sustained at 24 months and limited evidence
beyond 24 months. The strength of the evidence, however, is
limited; there was moderate heterogeneity and some evidence
for potential risk of bias in terms of allocation concealment and
outcome assessment as well as publication bias. All but 23 trials
reported results only for those participants who completed the
interventions, so results should be interpreted with caution.
Orlistat added to a lifestyle intervention seemed to be more
effective than placebo and lifestyle intervention. Heterogeneity
of effects was explained by a dose-response effect, with a dose
of 120mg three times a day reaching an effect estimate of −2.34
kg and treatment with lower doses a non-significant effect
estimate of −0.70 kg. There was also evidence for sustainable
effectiveness with orlistat 120 mg three times daily over 36
months. All orlistat studies report significant increases in adverse
effects in the form of an increased number of gastrointestinal
events in participants taking orlistat compared with placebo,
with some studies also reporting slight decreases in vitamin
concentrations, which were small and treatable with
supplementation. Undesirable gastrointestinal side effects could
limit acceptability at the individual level and therefore the
impact of the treatment at population level.60, Orlistat, however,
is normally prescribed alongside behaviour change. The
behavioural interventions in orlistat trials included in our review
provided extremely limited detail about the behaviour change
components, and it is unclear if effects could be further
optimised by pairing orlistat with the best evidence based
behavioural interventions.
For interventions focused on diet or physical activity alone,
using nutritional supplements or food replacements, we found
no evidence for effectiveness of these interventions. Only a few
studies tested these specific intervention components, and further
research is required to confirm this finding. We found no
significant evidence that specific modes of intervention delivery
were more effective, although face to face interventions
displayed a tendency to be more effective than remotely
delivered ones (such as internet or telephone). Face to face
interventions have limited scalability for population use, and it
is highly desirable to use new technologies and methods for
intervention design to develop methods that are both effective
and scalable.
Strengths and limitations
The main strength of this review is the comprehensive and
rigorous search and the meta-analytic synthesis of available
evidence from randomised trials of non-surgical interventions
for weight loss maintenance. Our findings, however, are
applicable only to the contexts in which the studies have been
conducted. Most included studies were conducted in the US
and Scandinavia. Research in different countries and cultural
settings would add to the generalisability.
Although energy prescriptions were poorly described in some
weight loss maintenance intervention arms, participants seemed
to receive advice to follow a regimen that continued to create
an energy deficit, which was perhaps an unrealistic expectation
for the long term. This obscures the important distinction
between weight loss and weight loss maintenance.
All but three trials in this review provided a standardised weight
loss treatment before allocating participants to different weight
loss maintenance arms. While this practice might be sensible
in terms of trial management, it could limit the generalisability
of the findings to those who respond well to the initial weight
loss treatment and does not provide an evidence base for weight
loss maintenance that takes into account themanyways in which
individuals initially lose weight.
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Comparison with other studies
This systematic review adds to our knowledge of weight loss
maintenance by providing a comprehensive evaluation of the
evidence base to identify what works in helping patients to keep
weight off after initial weight loss. Previous reviews have
focused on a narrow set of methods for weight loss
maintenance,10 criteria for inclusion of study by weight loss and
follow-up periods of limited clinical relevance,14 and narrative
rather than systematic reviews methods.13 While the overall
findings of our review might be seen as encouraging, further
research is needed to provide more rigorous evaluations of well
described replicable interventions with an explicit theoretical
underpinning over periods of more than 24 months.
Conclusions and policy implications
Comprehensive behavioural interventions targeting dietary and
physical activity behaviours are moderately effective in slowing
regain of weight in obese adults after initial weight loss for
follow-up periods of up to 24 months. Orlistat treatment in
addition to behaviour change is effective in reducing weight
regain, with clear evidence of a dose-response relation and some
evidence for effectiveness over 36 months. Side effects of this
drug should be considered and discussed with patients before
it is prescribed.
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What is already known on this topic
Behaviour change leads to moderate clinically meaningful changes in weight
After initial weight loss, most people regain lost weight
Maintenance of weight loss is crucial to uphold the health benefits of initial weight loss
What this study adds
Behavioural interventions dealing with diet and physical activity show small but significant benefits on weight loss maintenance for up
to 24 months
Pharmacological support from orlistat 120 mg three times daily also shows small but significant benefits on weight loss maintenance
for up to 36 months
Overall effects of behavioural/lifestyle interventions, both with and without orlistat, on weight loss maintenance are small, and further
research needs to focus on increasing effectiveness of interventions
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Table
Table Table| 1 Overall details of studies included in review of interventions for weight loss maintenance (see appendix 1 for more detailed
version of this table)
Weight loss maintenanceWeight loss
Length
(months)Interventions
Length
(months)Intervention
9/15a) Standard food—time dependent; b) standard
food—weight dependent; c) prepackaged food—time
dependent; d) prepackaged food—weight dependent
3VLCD (800 kcal/day) + BTAgras 1996, USA
12 and 3/12a) Lifestyle treatment (3 months) and meal replacement;
b) lifestyle treatment (3 months)
2Meal replacement (1100 kcal/day) + CBTAnnunziato 2009, USA
6/29a) Resistance training + group meetings; b) walking +
group meetings; c) group meetings
2LED (1200 kcal/day) for 2 weeks and VLED
(500 kcal/day) for 6 weeks
Borg 2002, Finland
12/12a) Weekly meetings with dietician and formula products
(1/day); b) supervised exercise sessions; c) usual care
4a) LED (810 kcal/day) for 2 months,
hypo-energetic diet + 2 formula products
daily (~1200 kcal/day) for 2 months; b)
VLED (415 kcal/day) for 2 months,
hypo-energetic diet + 2 formula products
daily (~1200 kcal/day) for 2 months
Christensen 2013,
Denmark
12/12a) Internet delivered lifestyle intervention; b) self directed
weight management
4Moderate daily energy deficit (300-500
kcal/d) through diet and PA
Cussler 2008, USA
24/24a) Intensive support + high-carbohydrate diet; b) nurse
support + high-carbohydrate diet; c) intensive support +
high-monounsaturated-fat diet; d) nurse support +
high-monounsaturated-fat diet
—Various (community recruitment)Dale 2009, New Zealand
12/12a) Orlistat 60g + 4 behaviour modification sessions; b)
orlistat 120g + 4 behaviour modification sessions; c)
placebo + 4 behaviour modification sessions
12Orlistat 120 mg + controlled-energy dietDavidson 1999, USA
12/12a) High protein diet + monthly counselling; b) high
carbohydrate diet + monthly counselling
3VLED (500-550 kcal/d)Delbridge 2009, Australia
6/12a) Tapas acupressure technique–groups sessions ; b)
social support—group social support sessions
5Reduce calorie diet + BTElder 2012, USA
10/33a) 2-3h walking (1000 Kcal) + weekly meetings; b) 4-6h
walking (2000 Kcal) + weekly meetings; c) weekly meetings
4LED (weeks 1, 10-12) + VLED (weeks 2-9)
+ weekly group sessions
Fogelholm 2000, Finland
12/12a) Frequent in-person support; b) minimal in-person
support; c) Internet support
6Reduced energy intake of 1000 – 2500
kcal/day + increase in lifestyle activity + BT
Harvey-Berino 2002, USA
12/12a) Frequent in-person support; b) minimal in-person
support; c) internet support
6Reduced energy intake of 1000 – 2500
kcal/day + increase in lifestyle activity + BT
Harvey-Berino 2004, USA
12/12a) Orlistat 30mg + dietary and behavioural counselling; b)
orlistat 60mg + dietary and behavioural counselling; c)
orlistat 120mg + dietary and behavioural counselling; d)
placebo intervention + dietary/ behavioural counselling
6Hypoenergetic diet (deficit of 4180 kJ/d) +
brisk walking for 20-30 min 5 times/week
+ BT
Hill 1999, USA
12/12a) Mail/telephone contact for diet; b) mail/telephone contact
for exercise
12a) moderate energy restriction diet; b)
increased physical activity
King 1989, USA
12/12a) Skills focus programme; b) weight focus programme4Weight loss programmeKramer 1986, USA
20/20a) Intermittent group: VLCD every 3 months for 2 weeks;
b) on demand group: VLCD when weight regain occurred
4VLCD (450 kcal/day)Lantz 2003, Sweden
12/12a) CLA capsules + diet + educational diet programme; b)
placebo + diet + educational diet programme
2Energy restriction (3300-4200 kJ/d)Larsen 2006, Denmark
12/12a) Exercise focused maintenance; b) weight focused
maintenance
6Intake of 1200 kcal/day for women and
1500 kcal/ day for men + walking 30
minutes/day, 5 days/week + BT
Leermakers 1999, USA
12/15a) CBT; b) CBT + EFMA (enhanced food monitoring
accuracy); c) CBT + EFMA + reduced energy density
eating
2Meal replacement 1100 kcal/day +
increasing exercise (30 min most days)
Lowe 2008, USA
14/14a) Fibre supplement; b) no intervention control2VLCD (2 MJ/d)Pasman 1997, Netherlands
14/14a) 50 g carbohydrate +200 2g chromium-picolinate + 20
g fibre + 100 mg caffeine (CHO+); b) 50 g carbohydrate
(CHO); c) no intervention control
2VLCD (2 MJ/d)Pasman2 1997,
Netherlands
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Table (continued)
Weight loss maintenanceWeight loss
Length
(months)Interventions
Length
(months)Intervention
12/21a) Maintenance booster session ; b) multicomponent
maintenance programme
3BTPerri 1984a, USA
6/12a) Client-therapist contact by mail and telephone; b) no
treatment control
4a) Non-BT; b) BT including exchange list
diet plans; c) BT including exchange list
diet plans + relapse prevention
Perri 1984b, USA
12/18a) Multicomponent maintenance programme; b) no
treatment control
5BTPerri 1986, USA
7/18a) Peer self help group maintenance programme; b)
therapist-contact maintenance programme
5BTPerri 1987, USA
12/18a) Post-treatment contact; b) post-treatment contact +
social influence maintenance; c) post-treatment contact +
aerobic exercise maintenance ; d) post-treatment contact
+ aerobic exercise + social influence maintenance ; e) no
intervention control
5BTPerri 1988, USA
12/17a) Relapse prevention therapy (RPT); b) problem solving
therapy (PST); c) no intervention control
5BTPerri 2001, USA
12/12a) Telephone counselling; b) face-to-face counselling; c)
no intervention control
5BTPerri 2008, USA
36/36a) Lifestyle counselling for 3 years + orlistat 120 mg; b)
lifestyle counselling for 3 years + placebo
2VLED (600-800 kcal/day)Richelsen 2007,
Scandinavia
12/18a) Trans theoretical model tailored mail; b) generic info
about diet/exercise
6Clinic based weight management
programme
Riebe 2004, USA
12/12a) Hypocaloric diet + two sachets of meal replacement; b)
hypocaloric diet
3VLCD (330cal/day)Ryttig 1995, Sweden
12/12a) Hypocaloric diet; b) hypocaloric diet + three sachets of
meal replacement
3VLCD (330cal/day)Ryttig 1997, Sweden
24/24a) Guided intervention; b) self directed intervention—Various (community recruitment)Sherwood 2013, USA
12/12a) Diet + orlistat; b) diet + placebo12Hypocaloric diet + placebo 3 times/daySjostorm 1997a, Europe
12/12a) Diet + orlistat; b) diet + Placebo12Hypocaloric diet + orlistat 120 mg 3
times/day
Sjostorm 1997b, Europe
5/21a) Gourmet cooking course; b) neurolinguistic programming
(NLP)
3600 kcal-deficit diet + orlistatSorenson 2011, Denmark
30/30a) Monthly personal contact; b) unlimited access to an
interactive technology intervention; c) self directed control
6Weight loss programme (diet and exercise)Svetkey 2008, USA
12/24a) Ad lib, low fat high carbohydrate; b) fixed energy intake
diet
2 or 4a) LED (2 MJ/day) + anorectic compound
+ weekly BT (8 weeks); b) conventional
diet (5 MJ/day), + anorectic compound +
weekly BT (17 weeks)
Toubro 1997, Denmark
12/12a) Skill based intervention; b) motivation focused
maintenance programme
6Weight loss programme (diet and exercise)West 2011, USA
9/21a) Diet + corset + 2 meeting with GP; b) diet3VLCD (800 kcal/day) + BTWikstrand 2010, Sweden
12/12a) Telephone assisted weight management group; b) no
contact group
6a) Standard behaviour treatment (SBT); b)
SBT +meal plans; c) SBT + food provision;
d) SBT + food provision for free
Wing 1996a, USA
12/12a) Food provision + BT; b) BT6a) standard behaviour treatment (SBT); b)
SBT +meal plans; c) SBT + food provision;
d) SBT + food provision for free
Wing 1996b, USA
18/18a) Face-to-face group; b) internet; c) information only
control group
—Various (community recruitment)Wing 2006, USA
LED=low energy diet; VLCD=very low calorie diet; VLED=very low energy diet; WLM=weight loss maintenance; WL=weight loss; BT=behavioural therapy.
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Figures
Fig 1 Flowchart of systematic process for report identification
Fig 2 Risk of bias graph showing review authors’ judgments about each risk of bias item presented as percentages across
all included studies
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Fig 3Mean difference in weight change at 12 months after initial weight loss in behavioural/lifestyle studies. BC=behaviour
therapy + post-treatment therapy contact condition; BCA=behaviour therapy + post-treatment therapy contact + aerobic
exercise maintenance condition; BCAS=behaviour therapy + post treatment therapy contact + aerobic exercise maintenance
+ social influencemaintenance programme condition; F2F=face to face condition, FIPS=frequent in-person support condition;
MIPS=minimal in-person support condition; Int=internet condition; PST=problem solving therapy condition; RPT=relapse
prevention training condition; SF=skill focus condition, phone=telephone condition; WF=weight focus condition
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Fig 4 Mean difference in weight change at 12 months after initial weight loss in pharmacological intervention studies.
O120=orlistat 120 mg 3 times daily; O60=orlistat 60 mg 3 times daily; O30=orlistat 30 mg 3 times daily; OO vOP=comparison
between groups who lost weight using orlistat 120 mg and low energy diet for 1 year followed by randomisation to continued
orlistat 120 mg treatment or placebo condition; PO v PP=comparison between groups who lost weight using placebo and
low energy diet for 1 year followed by randomisation to continued orlistat 120 mg treatment or placebo condition
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